Danaher Corporation (DHR) climbed 2.97% on September 16, 2026, settling at $209.34. The advance extended a run of positive momentum for the life sciences and diagnostics conglomerate, which has now gained ground over the past week and month as well.
Over the trailing seven days, DHR added 1.97%, while the 30-day period showed a gain of 3.40%. The consistent upward movement across these timeframes reflects steady buying interest in the stock.
With a market capitalization of $142.88 billion, Danaher remains one of the larger companies in its sector. The single-session gain of 2.97% represented a notable move for a company of this size, where large daily swings are less common.
The stock's performance over the past month suggests a gradual but sustained appreciation in share value. Investors tracking DHR will note that each successive measurement period — one day, seven days, and thirty days — reflected positive returns through the September 16 close.
